|
|
August 20, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Brian Farmer, CEO of Inipharm |
| In
this Q&A, Farmer discusses the genetic
discovery that inspired Inipharm's
approach, why an oral small-molecule
strategy sets the company apart from
RNA-based competitors, early clinical
signals behind INI-822, and what it takes
to build a small team capable of advancing
a novel drug target. More |
|
|
- Regeneron: Pasatru (garetosmab-grts)
First and Only FDA-approved Treatment
Demonstrating Reduction in New Heterotopic
Ossification (HO) Lesions and
Clinician-Assessed Flare-ups in a
Placebo-controlled Trial in Adults With
Fibrodysplasia Ossificans Progressiva (FOP)
More
More
More*
More*
- Soft Bones: Calls for Improved Treatment
Access for HPP Patients in Korea
More
- Taiho Oncology and Cullinan Therapeutics:
Zipalertinib Plus Chemotherapy First-Line
Phase 3 REZILIENT3 Trial Data Selected for
Presidential Symposium Presentation at the
IASLC 2026 World Conference on Lung Cancer More
- Teva: U.S. FDA Accepts New Drug Application
(NDA) and Grants Priority Review for Ecopipam,
a First-in-Class Investigational Therapy for
Pediatric Patients With Tourette Syndrome More
- Vascarta: NIH Phase I Clinical Study of
Vas-101 in Sickle Cell Disease Begins More
|
|
- Big4Bio: On Your Mark Returns for
JPM Week 2027, With a Live Site Alongside
the Guide
More
- BioPharmCatalyst Weekly Watchlist: Key
PDUFAs Left for the Quarter More
- Intelligent Bio Solutions: Fiscal 2026
Full-Year Revenue Growth of 38%
Year-over-Year, Driven by Reader Installed
Base and High-Margin Cartridge Growth More
- InterCure: 1-for-5 Reverse Share Split More
- UroGen: Strategic Collaboration and
Investment Agreements With IntraGel to
Access Biodegradable Sustained-Release Gel
Platform and Expand Oncology Pipeline More
|
|
- Big4Bio CEO Weekly Q&A: Brian
Farmer, CEO of Inipharm More
- Biotech & Pharma Updates | August 19 More
- Human Multi-Organ Chip Offers New Insight
Into Cancer Metastasis
More
- More on Moderna’s Personalized
Cancer Vaccine Showing Success in Phase 3
Trial
More*
More* More
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- 11 Companies Hiring in New Jersey
More
- OPPORTUNITY: Chief Operating Officer, Remote
More
- OPPORTUNITY: Computational Scientist, New
York More
- OPPORTUNITY: Head of
Computational Method Development, Boston
More
- 7 Biopharma M&A Deals Where Layoffs
Followed More
- Slone Partners: Fractional
Leadership in Biotech and Life Sciences -
When it Works and Why More
- Slone Partners: Places Farhad Ghavami as
Chief Executive Officer at SeqCenter More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|